Chirs Schott

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) collapsed to a new 52-week low of $88.50 on Wednesday before slightly rebounding but have still lost more than 50 percent over the past three months.. Citron Research published what it considered to be a "smoking gun" report on Wednesday which...